Global Metabolic Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Metabolic Disorder Therapeutics Market Overview

• 1.1 Product Overview and Scope of Metabolic Disorder Therapeutics
• 1.2 Classification of Metabolic Disorder Therapeutics by Types
  • 1.2.1 Global Metabolic Disorder Therapeutics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Types in 2018
  • 1.2.3 Lysosomal Storage Diseases
  • 1.2.4 Diabetes
  • 1.2.5 Obesity
  • 1.2.6 Inherited Metabolic Disorders
  • 1.2.7 Hypercholesterolemia
• 1.3 Global Metabolic Disorder Therapeutics Market by Application
  • 1.3.1 Global Metabolic Disorder Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Oral
  • 1.3.3 Parenteral
  • 1.3.4 Others
• 1.4 Global Metabolic Disorder Therapeutics Market by Regions
  • 1.4.1 Global Metabolic Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Metabolic Disorder Therapeutics (2014-2024)

2 Manufacturers Profiles

• 2.1 Novo Nordisk A/S
  • 2.1.1 Business Overview
  • 2.1.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Sanofi S.A.
  • 2.2.1 Business Overview
  • 2.2.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Sanofi S.A. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Boehringer Ingelheim GmbH
  • 2.3.1 Business Overview
  • 2.3.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Eli Lilly and Company
  • 2.4.1 Business Overview
  • 2.4.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Eli Lilly and Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Merck KgaA
  • 2.5.1 Business Overview
  • 2.5.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Merck KgaA Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Amgen, Inc.
  • 2.6.1 Business Overview
  • 2.6.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Amgen, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 AstraZeneca PLC
  • 2.7.1 Business Overview
  • 2.7.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 AstraZeneca PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Actelion Pharmaceuticals Ltd.
  • 2.8.1 Business Overview
  • 2.8.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Shire PLC
  • 2.9.1 Business Overview
  • 2.9.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Shire PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 AbbVie, Inc.
  • 2.10.1 Business Overview
  • 2.10.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 AbbVie, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Biocon Ltd.
  • 2.11.1 Business Overview
  • 2.11.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Biocon Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 BioMarin Pharmaceutical, Inc.
  • 2.12.1 Business Overview
  • 2.12.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Bristol-Myers Squibb Company
  • 2.13.1 Business Overview
  • 2.13.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Cipla, Inc.
  • 2.14.1 Business Overview
  • 2.14.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Cipla, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 CymaBay Therapeutics, Inc.
  • 2.15.1 Business Overview
  • 2.15.2 Metabolic Disorder Therapeutics Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Metabolic Disorder Therapeutics Market Competition, by Players

• 3.1 Global Metabolic Disorder Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Metabolic Disorder Therapeutics Players Market Share
  • 3.2.2 Top 10 Metabolic Disorder Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Global Metabolic Disorder Therapeutics Market Size by Regions

• 4.1 Global Metabolic Disorder Therapeutics Revenue and Market Share by Regions
• 4.2 North America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

5 North America Metabolic Disorder Therapeutics Revenue by Countries

• 5.1 North America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

6 Europe Metabolic Disorder Therapeutics Revenue by Countries

• 6.1 Europe Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Metabolic Disorder Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

8 South America Metabolic Disorder Therapeutics Revenue by Countries

• 8.1 South America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Metabolic Disorder Therapeutics by Countries

• 9.1 Middle East and Africa Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)

10 Global Metabolic Disorder Therapeutics Market Segment by Type

• 10.1 Global Metabolic Disorder Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Metabolic Disorder Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Lysosomal Storage Diseases Revenue Growth Rate (2014-2024)
• 10.4 Diabetes Revenue Growth Rate (2014-2024)
• 10.5 Obesity Revenue Growth Rate (2014-2024)
• 10.6 Inherited Metabolic Disorders Revenue Growth Rate (2014-2024)
• 10.7 Hypercholesterolemia Revenue Growth Rate (2014-2024)

11 Global Metabolic Disorder Therapeutics Market Segment by Application

• 11.1 Global Metabolic Disorder Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Metabolic Disorder Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Oral Revenue Growth (2014-2019)
• 11.4 Parenteral Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Metabolic Disorder Therapeutics Market Size Forecast (2019-2024)

• 12.1 Global Metabolic Disorder Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Metabolic Disorder Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology